Bristol Myers Squibb

As we kick off Veteran and Military Appreciation Month at Bristol Myers Squibb, I’m reminded that our commitment to the military community is something we celebrate every day. In a time of great change, this year’s theme, “Thriving Through Transformation,” could not be more fitting. We in the military community experience constant change and learn how to navigate military life’s challenges. It is a superpower that makes us stand out and enables us to lift those around us.   What makes this month truly special is the opportunity to showcase all that we as the Veterans Community Network have accomplished throughout the year with our colleagues, partners, and friends. I’m especially looking forward to sharing the incredible stories of those who have served, are currently serving, and the families who support them and “hold down the fort” while they are away. As a Marine Corps veteran, sharing and hearing these personal stories contributes to the deep sense of camaraderie that we strive so hard to create throughout our company.   It’s also exciting to see our most senior leaders actively participate in honoring our heroes, leading the charge in demonstrating the deep respect and gratitude we have for the sacrifices made by our military community. Here’s to a month of celebration, reflection, and appreciation for all who serve and support! #BMS_Employee #ThrivingThroughTransformation #2025VeteransSalute

As part of our vision to transform patients’ lives through science, we are committed to addressing the needs of people living with neurological and neuropsychiatric conditions – pursuing bold science while always keeping patients at the center. Hear from Dr. Ken Kramer, PhD as our team prepares to attend the upcoming NEI Fall Congress, and learn more about our work in neuroscience: https://bit.ly/3X6bO6O #OneBMS

“Even though you’re CEO, you rely on the leverage that you get from your team and having a great team that works with you every single day.” As Chris Boerner begins his third year as CEO, he shares his learnings from the past two years in the latest episode of Trials to Transformation. #TrialstoTransformation #OneBMS

We're showcasing new data at #AHA25 highlighting how our legacy of bold science and cardiovascular innovation is advancing patient care. Explore the growing body of long-term and real-world data from our cardiovascular portfolio: https://bit.ly/4qEm045

Earlier today, we announced another quarter of strong earnings results, reflecting continued execution across the business as we progress our long-term growth strategy. In Q3, we built on momentum generated in the first half of the year, delivering another quarter of double-digit growth in our Growth Portfolio. We also achieved important clinical and regulatory milestones while enhancing our portfolio through business development. As we look toward year’s end, our focus remains on delivering transformational medicines for patients and driving sustainable growth. Read more, including important cautionary statements about forward-looking information, here: https://bit.ly/3LkEpm9

Together with Johnson & Johnson Innovative Medicine, we’re investigating new ways to prevent more strokes without significantly increasing the risk of bleeding. Through our research on Factor XIa (FXIa), a promising therapeutic target, we are working to close the gap in stroke care. On #WorldStrokeDay, it is important to acknowledge that stroke continues to be a major contributor to mortality and disability on a global scale. Approximately one quarter of individuals who experience a stroke remain at risk for a second stroke within five years. Explore key facts about stroke and our commitment to advancing research aimed at improving prevention and outcomes: https://bit.ly/3X1vbxP #OneBMS

Mental health conditions like schizophrenia are some of the most misunderstood and stigmatized conditions. We remain committed to shifting the narrative around the condition by showcasing the power honest conversations can have, coupled with connection, support and finding the right treatment. Learn more: https://bit.ly/42YEGkV

Bringing people together and hearing personal experiences of living with blood cancer firsthand is a crucial part of understanding the real-world impact of this innovative treatment option. We recently hosted #CARTCellTherapy patients and their care partners to understand their CAR T treatment journey and discussed strategies for improving patient education. It was an honor to connect with these individuals and it reinvigorated our motivation to deliver innovative treatments to patients with blood cancers. Discover more about the science behind cell therapy and our ongoing research: https://bit.ly/3X4mByd #OneBMS

We continue to push the boundaries in immune-mediated diseases. Hear our perspective on a sequential immunotherapy research framework designed to address the root cause of disease as we aim to deliver transformational advances for patients in need: https://bit.ly/4hm3aKE #ACR25 #OneBMS